Pine Pharmaceuticals Recalls Bevacizumab Syringes Due to Silicone Oil Microdroplets
Pine Pharmaceuticals is recalling specific lots of bevacizumab syringes for intravitreal use due to the presence of silicone oil microdroplets.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The agency classified this as an FDA Class II recall. According to the rubric, FDA Class II recalls involving significant injury or property damage reports, or those not explicitly stated as having no reported illness, are categorized as Severe (Score 4).
Plain-English summary
Pine Pharmaceuticals, LLC is recalling specific lots of Bevacizumab 1.25 mg/0.05 mL filled to 0.06 mL in 3/10 mL 31 G 5/16" Syringes for intravitreal use. The recall is being conducted because of the presence of particulate matter, specifically silicone oil microdroplets, in the syringes.
The affected lots are 1648@7 with an expiration date of 12/20/2015, and 1428@4 with an expiration date of 11/17/2015. These products were distributed nationwide and in Puerto Rico.
Healthcare providers and patients should stop using the affected syringes and contact Pine Pharmaceuticals for further instructions or a replacement.
The recalled product
- Product
- Bevacizumab 1.25 mg/0.05 mL filled to 0.06 mL in 3/10 mL 31 G 5/16" Syringe for intravitreal, Rx -- Pine Pharmaceuticals, 100 Colvin Woods Pkwy Suite 300, Tonawanda, NY 14150.
- Manufacturer
- Pine Pharmaceuticals, LLC
- Category
- Drug — Ophthalmic
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (4)
- Lot #: 1648@7
- exp. 12/20/2015
- 1428@4
- exp. 11/17/2015
Distribution
Part of a larger recall action
This product is one of 4 recalled by Pine Pharmaceuticals, LLC under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 4 products in this recall →Related recalls
Same manufacturer · Pine Pharmaceuticals, LLC
See all →- HighFDA Recalls Compounded Moxifloxacin Syringes for Lack of Sterility Assurance
FDA (Drugs) · 2023-10-25
- HighTPC Drops Ophthalmic Solution Recalled for Lack of Sterility Assurance
FDA (Drugs) · 2023-10-25
- HighFoscarnet Sodium Injectable Recalled Due to Lack of Sterility Assurance
FDA (Drugs) · 2023-10-25
- HighLidocaine eye drops recalled due to lack of sterility assurance
FDA (Drugs) · 2023-10-25
- HighEndophth Kit Recalled Due to Lack of Sterility Assurance
FDA (Drugs) · 2023-10-25
Same hazard · particulate matter
See all →- SevereACTHAR Gel Recalled for Presence of Glass and Stopper Particulate Matter
FDA (Drugs) · 2026-09-02
- SevereB. Braun Recalls Lactated Ringer's Injection Due to Particulate Matter
FDA (Drugs) · 2026-09-02
- SevereAmerican Regent Recalls Atropine Sulfate Injection Due to Particulate Matter
FDA (Drugs) · 2026-08-26
- SevereFDA Recalls Nicardipine Hydrochloride Injection Due to Particulate Matter
FDA (Drugs) · 2026-08-26
- SevereAmerican Regent Recalls Multrys Trace Elements Injection Due to Particulate Matter
FDA (Drugs) · 2026-08-26